Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Seamless Two-Stage Phase I/II Trial Design With Backfill and Joint Monitoring for Dose Optimization.

Pharmaceutical statistics·2026
Same author

Phase 1/1b study of BCMA-targeting bispecific T-cell engager pavurutamab in relapsed/refractory multiple myeloma.

Blood·2026
Same author

A Constrained Hierarchical Bayesian Model Considering Latent Biomarker Subgroups for Time-To-Event Endpoints in Randomized Phase II Trials.

Pharmaceutical statistics·2026
Same author

Simple imputation method for meta-analysis of survival rates when precision information is missing.

Research synthesis methods·2026
Same author

Multi-armed bandits backfill Bayesian optimal interval design.

Journal of biopharmaceutical statistics·2025
Same author

Statistical Consideration for Event-Free Survival With Cure Rate in Acute Myeloid Leukemia Studies.

Pharmaceutical statistics·2025
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
查看所有相关文章

相关实验视频

Updated: Jul 4, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

一个概括的贝叶斯最佳间隔设计,用于免疫治疗中剂量优化.

Qing Xia1, Kentaro Takeda2, Yusuke Yamaguchi2

  • 1Global Biostatistics Science, Amgen Inc, Camarillo, California, USA.

Pharmaceutical statistics
|January 31, 2024
PubMed
概括
此摘要是机器生成的。

一个新的剂量检测试验设计,gBOIN-ETI,有效地确定了新型免疫瘤治疗的最佳剂量. 它通过在临床试验中更好地平衡疗效,毒性和免疫反应,优于现有方法.

关键词:
贝叶斯的自适应剂量检测设计.剂量优化剂量优化有效度等级是有效度等级.免疫反应的免疫反应.模型辅助设计模型辅助设计毒性等级 毒性等级 毒性等级

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

相关实验视频

Last Updated: Jul 4, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 临床试验设计 临床试验设计

背景情况:

  • 开发新的免疫瘤疗法需要精确的剂量发现,以平衡疗效和毒性.
  • 传统的剂量确定方法在免疫疗法中与复杂的剂量结果关系作斗争.

研究的目的:

  • 引入一种新的一般化贝叶斯最佳间隔设计用于免疫疗法 (gBOIN-ETI).
  • 同时考虑有效性,毒性等级和免疫反应,以确定最佳剂量.

主要方法:

  • gBOIN-ETI设计是一种模型辅助的方法,用于高效的免疫疗法开发.
  • 模拟将gBOIN-ETI的操作特征与其他瘤剂量检测设计进行了比较.

主要成果:

  • 在选择正确的最佳剂量方面,gBOIN-ETI设计表现出卓越的性能.
  • 它还显示,在各种试验环境中,分配给最佳剂量的患者比例更高.

结论:

  • 在新型免疫瘤治疗中,gBOIN-ETI设计提供了一种高效有效的剂量确定方法.
  • 这种设计通过全面评估多种结果来改进现有方法.